• Consider SMH as a hedge for concentrated semiconductor longs, since it was described as highly correlated with the broader market; size any hedge carefully, as it may not offset company-specific losses.
• The clearest bearish ideas were IONQ, QBTS, and RGTI, but these volatile short candidates came with no price targets or catalysts, so research and risk limits are essential.
• LRCX, ADI, and ALAB were also floated as potential semiconductor shorts against long holdings, without supporting valuation analysis.
• MRNA was called a short-term short opportunity around $213–$215, but this was a trading view without a stated target or timeframe.

Semiconductor Exposure and Hedging (SMH, SPY)

• The speaker criticized a portfolio holding several semiconductor stocks long without any shorts or hedges, arguing that it largely amounted to betting that the broader market would rise.
• SMH was described as a semiconductor ETF holding names including Nvidia (NVDA), Taiwan Semiconductor (TSM), AMD (AMD), Broadcom (AVGO), Micron (MU), Intel (INTC) and ASML (ASML). The speaker said it had an approximately 80% correlation with the S&P 500.
• The speaker suggested using SMH as a possible hedge against long semiconductor positions, or shorting it to express a view that selected semiconductor stocks would outperform the wider group.
• The stated risks of an unhedged long portfolio included a broad market decline, a negative announcement from Anthropic, or a geopolitical shock such as escalation involving Iran. The speaker argued that a hedge could reduce exposure to such market-wide moves.

Takeaways

• The discussion favors researching individual companies and balancing long and short positions over simply buying a group of correlated stocks. SMH was presented as a possible hedge, not as a specific trade recommendation for every investor.
• The transcript does not establish that any portfolio can reliably profit under every market outcome; the proposed hedging approach still carries investment risk.

Moderna (MRNA)

• The speaker described Moderna as unusually volatile and said its price action could appeal to traders.
• During the stream, the stock rose through roughly $213–$215. The speaker called it a “good short opportunity” while it was rising, saying it was popping “for no reason.”
• No valuation analysis, price target, or holding period was provided.

Takeaways

• The comments reflect a short-term bearish trading view, not a substantiated long-term investment thesis. The same volatility described as an opportunity can also increase the risk of losses, particularly for short sellers.

ASML (ASML)

• One participant was questioned for shorting ASML; the speaker called it “like the best company” and said he did not understand the short.
• ASML was also listed among the participant’s semiconductor longs. The speaker’s broader criticism was that a portfolio long several semiconductor stocks, without an offsetting position, would be exposed to a sector or market decline.

Takeaways

• The speaker pushed back on shorting ASML specifically, but did not provide a detailed valuation or earnings-based argument. The wider point was to assess ASML relative to other semiconductor holdings and manage correlated exposure.

Amphenol (APH)

• The speaker called Amphenol a “great long” while reviewing hardware stocks.

Takeaways

• This was a favorable view, but the transcript gave no supporting financial analysis, price target, or timeline. Treat it as a name for further research rather than a complete investment case.

Lam Research (LRCX)

• The speaker said he liked the idea of shorting Lam Research, and later described it as a possible short against the participant’s semiconductor positions.

Takeaways

• The short view was expressed as a potential way to offset long semiconductor exposure. The transcript did not give a specific catalyst, valuation case, or target, so further research would be needed before drawing a conclusion.

Quantum-Computing Companies: IonQ, D-Wave and Rigetti

• The speaker singled out IonQ (IONQ) as the “best short” on the hardware list and said he would be comfortable with the participant shorting it.
• D-Wave (QBTS) and Rigetti Computing (RGTI) were also described as good short candidates.
• The speaker cautioned that these names could be volatile. No price targets or specific catalysts were given.

Takeaways

• The transcript presents a clearly bearish view on these quantum-computing names, but it does not provide the research supporting that view. Their volatility, noted by the speaker, is especially relevant to anyone considering a short position.

Other Hardware and Semiconductor Stocks

• Wolfspeed (WOLF): The speaker said its sharp drop would have made it a good short. This was a retrospective observation, not an explicit current recommendation.
• Infineon (IFX): Described as a good name to consider, following a mention the previous day.
• Astera Labs (ALAB): Raised as a possible short.
• Analog Devices (ADI): Suggested as a possible short against the participant’s semiconductor longs.
• Lumentum (LITE): Described as “probably” a good short.
• Micron (MU): Mentioned as a potential stock to research for a short; no firm view was provided.
• AMD (AMD): The speaker noted that it had been “on a tear,” describing it as a stock that would have made a good long in hindsight.
• SanDisk (SNDK), Intel (INTC), Nvidia (NVDA), Broadcom (AVGO), Applied Materials (AMAT), ARM (ARM), Arista Networks (ANET), Texas Instruments (TXN), KLA (KLAC), Marvell (MRVL), Seagate (STX), Western Digital (WDC), Cisco (CSCO), Hewlett Packard Enterprise (HPE), and Pure Storage (PSTG) were discussed as names to review or as examples from the hardware-stock list. The speaker questioned the participant’s concentration in some of them but did not offer a clear standalone thesis for each.
• Cerebras and Lightmatter were mentioned in the discussion of potential research targets, but the transcript treats them as private companies. It also refers to Quantinuum, which is not presented as a publicly traded stock.

Takeaways

• The speaker’s central suggestion was to screen hardware companies for relative long and short opportunities instead of holding several semiconductor names that may move together.
• Most of these references are watchlist ideas or passing comments, not fully developed recommendations. The transcript does not supply company-level price targets or detailed financial analysis.

Apple (AAPL) and Verizon (VZ)

• Apple was said to be down about 3% during the stream. The speaker speculated that the decline might be related to reports or speculation that Elon Musk could make a phone.
• Verizon was also mentioned in connection with that speculation, but the transcript does not clearly explain the link or give a separate thesis for the company.

Takeaways

• These were brief market-move observations, not investment recommendations. The suggested connection to a potential Elon Musk phone was speculative in the transcript.

Humana (HUM), Ciena (CIEN) and Vivakor (VIVK?)

• Humana was noted as being up sharply, with no reason for the move discussed.
• Ciena (referred to as “Sienna” in the transcript) was said to be up about 15%; the speaker asked why, but no explanation followed.
• A company transcribed as “Vivacor” or “Vivecor” was also said to be up. The name and ticker are unclear in the transcript, so the identification as Vivakor (VIVK) is uncertain.

Takeaways

• These are intraday price observations only. The transcript provides no investment thesis, catalyst, or guidance for evaluating the moves.

Novo Nordisk (NVO) and ImmunityBio (IBRX)

• The speaker said he had not spent time researching Novo Nordisk (NVO) and expressed no interest in discussing it; no investment view was offered.
• ImmunityBio (IBRX) was described dismissively as a penny stock that the speaker’s group had shorted years earlier. No current position or fresh thesis was stated.

Takeaways

• Neither mention amounts to a current recommendation. The ImmunityBio comment refers to a past short, while the Novo Nordisk comment indicates a lack of research rather than a bearish view.

French and EU Debt

• A participant asked whether France had a “debt bubble” and whether it threatened EU markets. The transcript does not provide a substantive answer or discuss specific bonds, funds, or other investments.

Takeaways

• The question raises a macroeconomic concern, but the discussion supplies no evidence or investment conclusion. No actionable trade or timeline was stated.

Biotech Positions (Unspecified)

• The speaker said he was long one biotech and short another, but did not identify either company in that comment. Moderna was discussed separately as a potential short-term trading opportunity.

Takeaways

• The transcript does not provide enough information to identify or assess the unspecified biotech positions.